Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Orexin Receptor 2 ELISA Kit (AC3945)
Cat.#: ASET-2534
Specifications
Description Human Orexin Receptor 2 ELISA Kit allows for the in vitro quantitative determination of human Orexin Receptor 2 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 18.75 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 31.25-2000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1443 Human NPY5R ELISA Kit (AC2854) Quantitative inquiry ASET-2388 Rabbit CRH ELISA Kit (AC3799) Quantitative inquiry ASET-1913 Rat Tau ELISA Kit (AC3324) Quantitative inquiry ASET-1701 Rat CACNA1A ELISA Kit (AC3112) Quantitative inquiry ASET-1668 Rat SIRP alpha ELISA Kit (AC3079) Quantitative inquiry ASET-1895 Human TrkB ELISA Kit (AC3306) Quantitative inquiry ASET-1051 Human LAMP1 ELISA Kit (AC2462) Quantitative inquiry ASET-2109 Rat beta 1 Adrenergic Receptor ELISA Kit (AC3520) Quantitative inquiry ASET-1023 Human ACTH ELISA Kit (AC2434) Quantitative inquiry ASET-1528 Human Semaphorin 3F ELISA Kit (AC2939) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket